Clinical Cases in Lung Cancer

home / expert-perspective-tumor-board / clinical-cases-in-lung-cancer

Experts in lung oncology review 3 clinical cases and discuss individualized treatment approaches for each patient.

Case 1: 72-Year-Old Woman With Small Cell Lung Cancer

EP. 1: Case 1: 72-Year-Old Woman With Small Cell Lung Cancer

Targeted Oncology
August 31st 2020

Watch

Case 1: Extensive-Stage Small Cell Lung Cancer Background

EP. 2: Case 1: Extensive-Stage Small Cell Lung Cancer Background

Targeted Oncology
August 31st 2020

Watch

Case 1: IMpower133 Trial in Small Cell Lung Cancer

EP. 3: Case 1: IMpower133 Trial in Small Cell Lung Cancer

Targeted Oncology
August 31st 2020

Watch

Case 1: CASPIAN Trial in Extensive-Stage Small Cell Lung Cancer

EP. 4: Case 1: CASPIAN Trial in Extensive-Stage Small Cell Lung Cancer

Targeted Oncology
August 31st 2020

Watch

Case 1: Biomarkers in Small Cell Lung Cancer

EP. 5: Case 1: Biomarkers in Small Cell Lung Cancer

Targeted Oncology
August 31st 2020

Watch

Case 1: Small Cell Lung Cancer in the Era of Immunotherapy

EP. 6: Case 1: Small Cell Lung Cancer in the Era of Immunotherapy

Targeted Oncology
August 31st 2020

Watch

Case 2: 67-Year-Old Woman With EGFR+ Non–Small Cell Lung Cancer

EP. 7: Case 2: 67-Year-Old Woman With EGFR+ Non–Small Cell Lung Cancer

Targeted Oncology
August 31st 2020

Watch

Case 2: Biomarker Testing for Non–Small Cell Lung Cancer

EP. 8: Case 2: Biomarker Testing for Non–Small Cell Lung Cancer

Targeted Oncology
August 31st 2020

Watch

Case 2: EGFR-Positive Non–Small Cell Lung Cancer

EP. 9: Case 2: EGFR-Positive Non–Small Cell Lung Cancer

Targeted Oncology
August 31st 2020

Watch

Case 2: FLAURA Study for EGFR+ Metastatic NSCLC

EP. 10: Case 2: FLAURA Study for EGFR+ Metastatic NSCLC

Targeted Oncology
August 31st 2020

Watch

Case 2: EGFR+ NSCLC Combination Therapies

EP. 11: Case 2: EGFR+ NSCLC Combination Therapies

Targeted Oncology
August 31st 2020

Watch

Case 2: Treatment After Progression of EGFR+ NSCLC

EP. 12: Case 2: Treatment After Progression of EGFR+ NSCLC

Targeted Oncology
August 31st 2020

Watch

Case 3: 63-Year-Old Man With Unresectable Stage IIIA NSCLC

EP. 13: Case 3: 63-Year-Old Man With Unresectable Stage IIIA NSCLC

Targeted Oncology
August 31st 2020

Watch

Case 3: Molecular Testing in Stage III NSCLC

EP. 14: Case 3: Molecular Testing in Stage III NSCLC

Targeted Oncology
August 31st 2020

Watch

Case 3: Chemoradiation for Stage III NSCLC

EP. 15: Case 3: Chemoradiation for Stage III NSCLC

Targeted Oncology
August 31st 2020

Watch

Case 3: PACIFIC Trial in Unresectable Stage III NSCLC

EP. 16: Case 3: PACIFIC Trial in Unresectable Stage III NSCLC

Targeted Oncology
August 31st 2020

Watch

Case 3: Standard of Care in Unresectable Stage III NSCLC

EP. 17: Case 3: Standard of Care in Unresectable Stage III NSCLC

Targeted Oncology
August 31st 2020

Watch

Case 3: Management of Immune-Related Toxicities in Stage III NSCLC

EP. 18: Case 3: Management of Immune-Related Toxicities in Stage III NSCLC

Targeted Oncology
August 31st 2020

Watch